Masimo Corp (NAS:MASI)
$ 115.24 -0.92 (-0.79%) Market Cap: 6.12 Bil Enterprise Value: 6.97 Bil PE Ratio: 78.39 PB Ratio: 4.48 GF Score: 92/100

Masimo Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 08:15PM GMT
Release Date Price: $272.64 (-0.30%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you everyone for joining us today. I'm Drew Ranieri, a medical device analyst here at Morgan Stanley. It's my pleasure to have Micah Young, the CFO of Masimo Corporation, along with Eli Kammerman, Head of Investor Relations. So before we jump into Q&A, I just have to get this disclaimer out of the way first.

For important disclosures, please see morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. So Micah, Eli, thanks for joining us today. Micah, I'm going to hand it over to you for a brief overview of Masimo and then we'll jump into Q&A. So the floor is all yours.

Micah Young
Masimo Corporation - Executive VP of Finance & CFO

Absolutely. Thanks, Drew. Yes. So coming into this year, I think COVID brought a lot of uncertainties around the pace that we would see hospital census and patient volumes recover throughout the year. And as you know, our sensors track very closely with hospital census

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot